$327 Million is the total value of Samsara BioCapital, LLC's 41 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NVAX | Exit | NOVAVAX INC | $0 | – | -21,244 | -100.0% | -0.03% | – |
| Exit | ASTRIA THERAPEUTICS INC | $0 | – | -25,000 | -100.0% | -0.04% | – | |
| AGLE | Exit | AEGLEA BIOTHERAPEUTICS INC | $0 | – | -883,720 | -100.0% | -0.07% | – |
| TIL | Exit | INSTIL BIO INC | $0 | – | -1,788,280 | -100.0% | -0.17% | – |
| ELEV | Exit | ELEVATION ONCOLOGY INC | $0 | – | -830,565 | -100.0% | -0.22% | – |
| DBTX | Exit | DECIBEL THERAPEUTICS INC | $0 | – | -801,629 | -100.0% | -0.54% | – |
| Exit | DICE THERAPEUTICS INC | $0 | – | -202,773 | -100.0% | -1.65% | – | |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -308,151 | -100.0% | -2.13% | – |
| KDNY | Exit | CHINOOK THERAPEUTICS INC | $0 | – | -5,161,888 | -100.0% | -34.81% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Intercept Pharmaceuticals Inc | 20 | Q3 2023 | 24.0% |
| ALLAKOS INC | 20 | Q3 2023 | 23.0% |
| SUTRO BIOPHARMA INC | 20 | Q3 2023 | 10.1% |
| SYROS PHARMACEUTICALS INC | 16 | Q3 2022 | 11.6% |
| ATRECA INC | 16 | Q1 2023 | 7.4% |
| IVERIC BIO INC | 15 | Q2 2023 | 5.5% |
| ACLARIS THERAPEUTICS INC | 15 | Q3 2023 | 4.8% |
| RHYTHM PHARMACEUTICALS INC | 15 | Q3 2023 | 2.4% |
| ODONATE THERAPEUTICS INC | 14 | Q1 2022 | 14.9% |
| SPRINGWORKS THERAPEUTICS INC | 14 | Q4 2022 | 12.1% |
View Samsara BioCapital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-08-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR/A | 2023-02-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Samsara BioCapital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.